Source:http://linkedlifedata.com/resource/pubmed/id/15150077
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2004-8-19
|
pubmed:abstractText |
To develop a model for Epstein-Barr virus (EBV) pathogenesis in immunosuppressed hosts, we studied experimental infections of immunocompetent versus SHIV 89.6P-infected, immunosuppressed rhesus macaques with the EBV-related rhesus lymphocryptovirus (LCV). Primary LCV infection after oral inoculation of 4 immunocompetent animals was characterized by an acute viremia and seroconversion followed by asymptomatic LCV persistence. Four immunosuppressed macaques infected orally with LCV failed to develop an LCV-specific humoral response and viremia was more pronounced, but there was no evidence of LCV-induced lymphoproliferative disease. A more aggressive primary challenge was administered by intravenous inoculation of 10(8) autologous, LCV-immortalized B cells in 4 additional immunosuppressed animals. Two animals with modest immunosuppression remained asymptomatic, and 1 of 2 severely immunosuppressed animals developed an aggressive, monoclonal LCV-positive lymphoma. These studies demonstrate the potential for lymphomagenesis in an experimental model system for EBV infection and underscore the strength and depth of immune control in limiting LCV-induced lymphoproliferative disease.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-4971
|
pubmed:author |
pubmed-author:AsterJon CJC,
pubmed-author:CarvilleAngelaA,
pubmed-author:KaurAmitinderA,
pubmed-author:KlumppSherryS,
pubmed-author:KutokJeffery LJL,
pubmed-author:QuinkCarolC,
pubmed-author:RaoPasupuletiP,
pubmed-author:RivaillerPierreP,
pubmed-author:SimonMeredithM,
pubmed-author:WangFredF,
pubmed-author:WestmorelandSusanS
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1482-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15150077-Animals,
pubmed-meshheading:15150077-Antibodies, Viral,
pubmed-meshheading:15150077-B-Lymphocytes,
pubmed-meshheading:15150077-CD4 Lymphocyte Count,
pubmed-meshheading:15150077-Cell Line, Transformed,
pubmed-meshheading:15150077-Disease Models, Animal,
pubmed-meshheading:15150077-Epstein-Barr Virus Infections,
pubmed-meshheading:15150077-Herpesviridae Infections,
pubmed-meshheading:15150077-Immunocompetence,
pubmed-meshheading:15150077-Immunocompromised Host,
pubmed-meshheading:15150077-Lymphocryptovirus,
pubmed-meshheading:15150077-Lymphoma,
pubmed-meshheading:15150077-Macaca mulatta,
pubmed-meshheading:15150077-Simian Acquired Immunodeficiency Syndrome,
pubmed-meshheading:15150077-Viral Load,
pubmed-meshheading:15150077-Viremia
|
pubmed:year |
2004
|
pubmed:articleTitle |
Experimental rhesus lymphocryptovirus infection in immunosuppressed macaques: an animal model for Epstein-Barr virus pathogenesis in the immunosuppressed host.
|
pubmed:affiliation |
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|